angiotensin ii has been researched along with Atheroma in 45 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 41 (91.11) | 24.3611 |
| 2020's | 4 (8.89) | 2.80 |
| Authors | Studies |
|---|---|
| Balatskaya, M; Balatskiy, A; Filatova, J; Kalinina, N; Ozhimalov, I; Popov, V; Savina, A; Tkachuk, V | 1 |
| Aono, J; Hamaguchi, M; Ikeda, S; Inoue, K; Kakino, A; Kurata, M; Nakao, Y; Sakaue, T; Sawamura, T; Suehiro, C; Suzuki, J; Takahashi, K; Yamaguchi, O | 1 |
| Cassis, LA; Daugherty, A; Howatt, DA; Lu, HS; Moorleghen, JJ; Wu, C; Wu, CH | 1 |
| Chen, JJ; Ding, L; He, X; Hu, XM; Hua, YN; Lin, XM; Ping, BH; Wang, Q; Wu, CM; Yang, B; Zhang, RY; Zheng, L | 1 |
| Lei, H; Li, J; Li, L; Liu, H; Yi, J | 1 |
| Antoku, Y; Egashira, K; Honda, K; Ichi, I; Koga, JI; Matoba, T; Nakano, K; Tsutsui, H | 1 |
| Channon, KM; Douglas, G; Hale, AB; Kerr, AG; Patel, J | 1 |
| Golledge, J; Kinobe, R; Krishna, SM; Morton, SK; Moxon, JV; Phie, J | 1 |
| Li, J; Li, YP; Shen, ZJ; Xia, P; Xu, CS; Xu, JJ | 1 |
| Avery, EG; Balogh, A; Bartolomaeus, H; Dechend, R; Eckardt, KU; Fielitz, J; Forslund, SK; Gollasch, M; Grandoch, M; Haase, N; Hering, L; Höges, S; Homann, S; Kempa, S; Kozhakhmetov, S; Kräker, K; Krannich, A; Kusche-Vihrog, K; Kushugulova, A; Maase, M; Markó, L; Müller, DN; Rump, LC; Stegbauer, J; Tsvetkov, D; Wilck, N; Wundersitz, S; Yakoub, M; Zhumadilov, Z | 1 |
| Chen, LY; Hu, HY; Lu, YH; Pan, LN; Qu, XL; Wang, X; Wang, ZY | 1 |
| Li, W; Shu, S; Wang, L; Wu, Y; Yuan, Z; Zhang, Y; Zhou, J | 1 |
| Fang, C; Lin, L; Moore, A; Wen, G; Wu, S; Xiao, Q; Ye, S; Zhang, L | 1 |
| Gnanaselvi, SK; Gopal, K; Jahan, P; Jedy, J; Kumar, JM; Nagarajan, P; Raj, AT; Shankar, EM; Sharma, Y | 1 |
| Clancy, P; Golledge, J; Koblar, SA; Seto, SW | 1 |
| Karunakaran, D; Leenen, FH; Milne, RW; Rafatian, N; Rayner, KJ; Whitman, SC | 1 |
| Cho, S; Chung, JH; Jin, T; Kim, SH; Lee, D; Lee, KH; Lim, S; Park, H; Park, S | 1 |
| Miura, S; Saku, K | 1 |
| Hirata, Y; Ikutomi, M; Minami, Y; Morita, T; Nagai, R; Nakajima, T; Sahara, M; Sata, M | 1 |
| Ding, Z; Khaidakov, M; Mehta, JL; Mercanti, F; Romeo, F; Stone, A; Wang, X | 1 |
| Ayari, H; Bricca, G; Cerutti, C; Feugier, P; Gharbi-Chihi, J; Gustin, MP; Lantelme, P; Legedz, L; Li, JY; Lohez, O; Nehme, A | 1 |
| Cheng, XW; Hamrah, MS; Hao, CN; Hayashi, M; Hu, L; Kuzuya, M; Murohara, T; Shi, GP; Takeshita, K; Wu, H | 1 |
| Chai, M; Dong, Z; Ji, Q; Lin, Y; Liu, Y; Lu, Q; Meng, K; Wu, B; Yu, K; Zeng, Q; Zhang, J; Zhou, Y | 1 |
| Ait-Oufella, H; Mallat, Z; Potteaux, S | 1 |
| Bragina, ME; Caffa, I; Costa-Fraga, FP; da Silva, RF; Fraga-Silva, RA; Mach, F; Montecucco, F; Nencioni, A; Raizada, MK; Santos, RAS; Stergiopulos, N | 1 |
| Hirano, T; Hiromura, M; Kohashi, K; Kushima, H; Mori, Y; Nagashima, M; Shinmura, K; Terasaki, M; Tomoyasu, M; Watanabe, T | 1 |
| Amstutz, C; Aubert, JF; Bouzourène, K; Mazzolai, L; Pellegrin, M | 1 |
| Chen, X; Deng, Y; Ding, D; Hu, X; Liao, Y; Pan, Y; Qiu, Z; Song, X; Wang, M; Wang, S; Wu, H; Yang, S; Zhang, H; Zhou, Y; Zhou, Z | 1 |
| Egashira, K; Katsuki, S; Koga, J; Matoba, T; Nakano, K; Nakashiro, S; Sunagawa, K; Tokutome, M; Umezu, R | 1 |
| Clancy, P; Golledge, J; Koblar, S | 1 |
| Chen, Y; Chen, YE; Fan, J; Kang, D; Li, S; Liu, E; Niimi, M; Ning, B; Shiomi, M; Wang, YN; Wang, Z; Waqar, AB; Yu, Q; Zhang, J | 1 |
| Fan, F; Li, S; Nie, W; Yan, H; Zhang, X; Zhu, J; Zhu, W | 1 |
| Bricca, G; Kobeissy, F; Marcelo, P; Nasser, R; Nehme, A; Zibara, K | 1 |
| Chen, H; Cui, Y; Li, S; Liu, J; Song, J; Zhang, F | 1 |
| Ceconi, C; Ferrari, R; Guardigli, G | 1 |
| Cullen, B; Golledge, J; Moran, C; Rush, C | 1 |
| Guo, RW; Liu, H; Yang, LX; Yang, ZH; Ye, JS | 1 |
| Coelho, V; de Andrade, CR; Debbas, V; Kalil, J; Laurindo, FR; Rosa, DS; Stolf, BS | 1 |
| Sata, M | 1 |
| Aono, J; Higaki, J; Horiuchi, M; Inoue, K; Iwai, M; Nagai, T; Nishimura, K; Ogimoto, A; Okayama, H; Suzuki, J | 1 |
| Choi, S; Chung, MH; Ha, H; Huh, JY; Jo, H; Kim, B; Lee, HM; Lee, J; Lee, Y; Son, DJ | 1 |
| Cooper, ME; Du, XJ; Head, GA; Kiriazis, H; Nguyen-Huu, TP; Pickering, R; Thomas, MC; Tikellis, C; Tsorotes, D | 1 |
| Agrawal, DK; Gangahar, DM; Jia, G; Stormont, RM | 1 |
| Chen, XJ; He, B; Hu, LH; Jin, SX; Li, DD; Nie, P; Shen, LH; Yuan, W; Zhang, XK | 1 |
| Campbell, IC; Oshinski, JN; Suever, JD; Taylor, WR; Veneziani, A; Virmani, R; Vito, RP; Weiss, D | 1 |
4 review(s) available for angiotensin ii and Atheroma
| Article | Year |
|---|---|
Recent progress in the treatment of cardiovascular disease using olmesartan.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Coronary Artery Disease; Coronary Stenosis; Disease Models, Animal; Humans; Hypertension; Imidazoles; Plaque, Atherosclerotic; Tetrazoles | 2014 |
Role of splenic monocytes in atherosclerosis.
Topics: Angiotensin II; Animals; Atherosclerosis; Humans; Monocytes; Plaque, Atherosclerotic; Spleen | 2015 |
Secondary prevention of CAD with ACE inhibitors: a struggle between life and death of the endothelium.
Topics: Acute Coronary Syndrome; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Apoptosis; Atherosclerosis; Bradykinin; Cardiotonic Agents; Coronary Artery Disease; Disease Progression; Endothelial Cells; Endothelium, Vascular; Heart Failure; Humans; Hypertension; Peptidyl-Dipeptidase A; Perindopril; Plaque, Atherosclerotic; Randomized Controlled Trials as Topic; Secondary Prevention; Stem Cells | 2010 |
[Role of chronic inflammation in the pathogenesis of atherosclerosis].
Topics: Adipokines; Adipose Tissue; Angiotensin II; Animals; Atherosclerosis; Chronic Disease; Coronary Vessels; Cytokines; Humans; Inflammation; Inflammation Mediators; Life Style; Macrophages; Neovascularization, Pathologic; Plaque, Atherosclerotic; Vascular Endothelial Growth Factor A | 2011 |
41 other study(ies) available for angiotensin ii and Atheroma
| Article | Year |
|---|---|
Immature Vascular Smooth Muscle Cells in Healthy Murine Arteries and Atherosclerotic Plaques: Localization and Activity.
Topics: Aging; Angiotensin II; Animals; Aorta, Thoracic; Arteries; Carotid Artery, Common; Cell Movement; Cell Proliferation; Cells, Cultured; Immunophenotyping; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Plaque, Atherosclerotic; Receptor, Angiotensin, Type 2; Shear Strength; Stress, Mechanical | 2022 |
LOX-1 deficiency increases ruptured abdominal aortic aneurysm via thinning of adventitial collagen.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Atherosclerosis; Collagen; Disease Models, Animal; Inflammation; Mice; Mice, Inbred C57BL; Mice, Knockout, ApoE; Plaque, Atherosclerotic; Scavenger Receptors, Class E | 2023 |
Two Amino Acids Proximate to the Renin Cleavage Site of Human Angiotensinogen Do Not Affect Blood Pressure and Atherosclerosis in Mice-Brief Report.
Topics: Amino Acid Substitution; Angiotensin II; Angiotensinogen; Animals; Atherosclerosis; Blood Pressure; Disease Models, Animal; Female; Hepatocytes; Humans; Hypertension; Male; Mice, Knockout; Plaque, Atherosclerotic; Receptors, LDL; Renin; Species Specificity | 2020 |
LncRNA AC105942.1 Downregulates hnRNPA2/B1 to Attenuate Vascular Smooth Muscle Cells Proliferation.
Topics: Angiotensin II; Cell Proliferation; Down-Regulation; Gene Knockdown Techniques; Heterogeneous-Nuclear Ribonucleoprotein Group A-B; Humans; Models, Biological; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Plaque, Atherosclerotic; RNA, Long Noncoding | 2021 |
Dose-Effect of Irbesartan on Cyclooxygenase-2 and Matrix Metalloproteinase-9 Expression in Rabbit Atherosclerosis.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Aortic Diseases; Atherosclerosis; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Irbesartan; Lipids; Male; Matrix Metalloproteinase 9; NF-kappa B; Plaque, Atherosclerotic; Rabbits; Signal Transduction | 2018 |
Lipid-Lowering Therapy With Ezetimibe Decreases Spontaneous Atherothrombotic Occlusions in a Rabbit Model of Plaque Erosion: A Role of Serum Oxysterols.
Topics: Angiotensin II; Animals; Anticholesteremic Agents; Arterial Occlusive Diseases; Atherosclerosis; Biomarkers; Cells, Cultured; Cholesterol, Dietary; Diet, High-Fat; Disease Models, Animal; Down-Regulation; Ezetimibe; Femoral Artery; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Oxysterols; Plaque, Atherosclerotic; Rabbits; Rats; Rosuvastatin Calcium; Signal Transduction; Thrombosis; Vascular System Injuries | 2018 |
Effect of irradiation and bone marrow transplantation on angiotensin II-induced aortic inflammation in ApoE knockout mice.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Aorta, Thoracic; Aortic Aneurysm, Abdominal; Aortic Aneurysm, Thoracic; Aortic Rupture; Aortitis; Atherosclerosis; Bone Marrow Transplantation; Disease Models, Animal; Macrophages; Male; Mice, Knockout, ApoE; Monocytes; Plaque, Atherosclerotic; Whole-Body Irradiation | 2018 |
A diet enriched with tree nuts reduces severity of atherosclerosis but not abdominal aneurysm in angiotensin II-infused apolipoprotein E deficient mice.
Topics: Angiotensin II; Animal Feed; Animals; Aorta, Abdominal; Aorta, Thoracic; Aortic Aneurysm, Abdominal; Aortic Diseases; Atherosclerosis; Brachiocephalic Trunk; Dilatation, Pathologic; Disease Models, Animal; Fatty Acids, Omega-3; Male; Mice, Knockout, ApoE; Nutritive Value; Nuts; Plaque, Atherosclerotic; Polyphenols; Severity of Illness Index; Time Factors | 2018 |
Telmisartan inhibits Ang II-induced MMP-9 expression in macrophages in stabilizing atheromatous plaque.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Cell Line; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Humans; Macrophages; Matrix Metalloproteinase 9; Plaque, Atherosclerotic; Telmisartan | 2018 |
Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Aortic Diseases; Arrhythmias, Cardiac; Arterial Pressure; Atherosclerosis; Cardiomegaly; Disease Models, Animal; Hypertension; Male; Mice, Knockout, ApoE; Plaque, Atherosclerotic; Propionates; T-Lymphocytes, Regulatory; Th17 Cells | 2019 |
Activation of the STAT3/microRNA-21 pathway participates in angiotensin II-induced angiogenesis.
Topics: Angiogenesis Inducing Agents; Angiotensin II; Animals; Cell Movement; Cell Proliferation; Endothelial Cells; Gene Expression Regulation; Humans; Mice; MicroRNAs; Neovascularization, Pathologic; Plaque, Atherosclerotic; PTEN Phosphohydrolase; Signal Transduction; STAT3 Transcription Factor | 2019 |
The role of monocyte chemotactic protein-induced protein 1 (MCPIP1) in angiotensin II-induced macrophage apoptosis and vulnerable plaque formation.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Disease Models, Animal; Endoplasmic Reticulum Stress; Losartan; Macrophages, Peritoneal; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mice, Knockout, ApoE; Plaque, Atherosclerotic; RAW 264.7 Cells; Receptor, Angiotensin, Type 1; Ribonucleases; RNA, Small Interfering | 2019 |
An important role of matrix metalloproteinase-8 in angiogenesis in vitro and in vivo.
Topics: Aneurysm; Angiotensin I; Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; beta Catenin; Cell Movement; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Gene Knockdown Techniques; Human Umbilical Vein Endothelial Cells; Humans; Matrix Metalloproteinase 8; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; Neovascularization, Physiologic; Plaque, Atherosclerotic; Platelet Endothelial Cell Adhesion Molecule-1; RNA Interference; Time Factors; Transfection | 2013 |
β-Carotene Attenuates Angiotensin II-Induced Aortic Aneurysm by Alleviating Macrophage Recruitment in Apoe(-/-) Mice.
Topics: alpha-Tocopherol; Angiotensin II; Animals; Antioxidants; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apolipoproteins E; beta Carotene; Cholesterol, LDL; Dietary Supplements; Disease Models, Animal; Lymphocytes; Macrophages; Male; Mice, Knockout; Organ Size; Plaque, Atherosclerotic | 2013 |
Role of the angiotensin converting enzyme 1/angiotensin II/angiotensin receptor 1 axis in interstitial collagenase expression in human carotid atheroma.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Carotid Artery Diseases; Collagenases; Dipeptides; Elastin; Endarterectomy, Carotid; Extracellular Matrix; Humans; Irbesartan; Matrix Metalloproteinase 1; Matrix Metalloproteinase 13; Matrix Metalloproteinase 8; Matrix Metalloproteinase Inhibitors; Organ Culture Techniques; Peptides; Peptidyl-Dipeptidase A; Plaque, Atherosclerotic; Quinapril; Receptor, Angiotensin, Type 1; Signal Transduction; Tetrahydroisoquinolines; Tetrazoles | 2013 |
Cathepsin G deficiency decreases complexity of atherosclerotic lesions in apolipoprotein E-deficient mice.
Topics: Angiotensin II; Animals; Aorta; Apolipoproteins E; Apoptosis; Atherosclerosis; Cathepsin G; Diet, High-Fat; Macrophages; Male; Mice; Mice, Knockout; Phagocytosis; Plaque, Atherosclerotic | 2013 |
The effect of soluble RAGE on inhibition of angiotensin II-mediated atherosclerosis in apolipoprotein E deficient mice.
Topics: Angiotensin II; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Biomarkers; Blood Pressure; Cell Adhesion Molecules; Gene Expression Regulation; Gene Knockout Techniques; Humans; Inflammation; Male; Mice; Muscle, Smooth, Vascular; Plaque, Atherosclerotic; Rats; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Solubility | 2013 |
Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Aorta; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Femoral Artery; Gene Deletion; Genetic Predisposition to Disease; Inflammation Mediators; JNK Mitogen-Activated Protein Kinases; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Peptidyl-Dipeptidase A; Phenotype; Plaque, Atherosclerotic; Protein Kinase Inhibitors; RNA Interference; Signal Transduction; Transfection; Vascular System Injuries | 2014 |
Gene and microRNA transcriptional signatures of angiotensin II in endothelial cells.
Topics: Angiotensin II; Cell Culture Techniques; Cell Proliferation; Coronary Vessels; Endothelial Cells; Gene Expression Regulation; Humans; MicroRNAs; Neovascularization, Pathologic; Plaque, Atherosclerotic; Proto-Oncogene Proteins; Receptor, Notch4; Receptors, CXCR4; Receptors, Notch; Signal Transduction; SOXF Transcription Factors; STAT3 Transcription Factor | 2015 |
Mutual amplification of corticosteroids and angiotensin systems in human vascular smooth muscle cells and carotid atheroma.
Topics: Adrenal Cortex Hormones; Aged; Angiotensin II; Angiotensins; Carotid Arteries; Cell Differentiation; Cell Transdifferentiation; Fludrocortisone; Humans; Hydrocortisone; Lipids; Muscle Contraction; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phenotype; Plaque, Atherosclerotic; Receptors, Mineralocorticoid | 2014 |
Renin inhibition reduces atherosclerotic plaque neovessel formation and regresses advanced atherosclerotic plaques.
Topics: Amides; Angiotensin II; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Blood Pressure; Carrier Proteins; Cathepsins; Chemokine CCL2; Extracellular Matrix; Fumarates; Gene Silencing; Human Umbilical Vein Endothelial Cells; Humans; Hydralazine; Immunohistochemistry; Intracellular Signaling Peptides and Proteins; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; Nuclear Proteins; Plaque, Atherosclerotic; Receptor, Angiotensin, Type 1; Renin; Toll-Like Receptor 2; Treatment Outcome; Vascular Cell Adhesion Molecule-1 | 2014 |
Valsartan Attenuates Atherosclerosis via Upregulating the Th2 Immune Response in Prolonged Angiotensin II-Treated ApoE(-/-) Mice.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antibodies, Monoclonal; Apolipoproteins E; Atherosclerosis; Blood Pressure; Body Weight; Disease Models, Animal; Inflammation; Interleukin-5; Lipids; Male; Mice; Mice, Knockout; Plaque, Atherosclerotic; T-Lymphocyte Subsets; Th2 Cells; Valsartan | 2015 |
Diminazene enhances stability of atherosclerotic plaques in ApoE-deficient mice.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Carotid Arteries; Collagen; Diminazene; Disease Models, Animal; Intercellular Adhesion Molecule-1; Macrophages; Mice; Mice, Inbred C57BL; Peptidyl-Dipeptidase A; Plaque, Atherosclerotic; Vascular Cell Adhesion Molecule-1 | 2015 |
A Dipeptidyl Peptidase-4 Inhibitor but not Incretins Suppresses Abdominal Aortic Aneurysms in Angiotensin II-Infused Apolipoprotein E-Null Mice.
Topics: Angiotensin II; Animals; Aorta; Aortic Aneurysm, Abdominal; Apolipoproteins E; Blood Pressure; Dipeptidyl-Peptidase IV Inhibitors; Gastric Inhibitory Polypeptide; Gene Expression Regulation; Glucagon-Like Peptide 1; Incretins; Inflammation; Interleukin-1beta; Male; Matrix Metalloproteinase 9; Mice; Mice, Knockout; Plaque, Atherosclerotic; Tissue Inhibitor of Metalloproteinase-2 | 2016 |
Voluntary Exercise Stabilizes Established Angiotensin II-Dependent Atherosclerosis in Mice through Systemic Anti-Inflammatory Effects.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Apolipoproteins E; Atherosclerosis; Biomarkers; CD4-Positive T-Lymphocytes; Cytokines; Disease Models, Animal; Inflammation Mediators; Macrophages; Mice; Mice, Knockout; Phenotype; Physical Conditioning, Animal; Plaque, Atherosclerotic | 2015 |
ATRQβ-001 vaccine prevents atherosclerosis in apolipoprotein E-null mice.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antibodies, Neutralizing; Aorta; Apolipoproteins E; Apoptosis; Atherosclerosis; Chemokine CCL2; Coronary Vessels; Endothelial Cells; Humans; Macrophages; Male; Mice; Mice, Knockout; Plaque, Atherosclerotic; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Scavenger Receptors, Class E; Vaccines; Valsartan; Vasoconstrictor Agents | 2016 |
Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice.
Topics: Administration, Intravenous; Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Brachiocephalic Trunk; Cardiovascular Agents; Cathepsins; Cell Differentiation; Cells, Cultured; Chemistry, Pharmaceutical; Cytokines; Diet, High-Fat; Disease Models, Animal; Disease Progression; Drug Carriers; Inflammation Mediators; Lactic Acid; Macrophages, Peritoneal; Male; Matrix Metalloproteinases; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Nanoparticles; Phenotype; Pioglitazone; Plaque, Atherosclerotic; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rupture, Spontaneous; Thiazolidinediones | 2016 |
Involvement of Angiotensin II Type 1 and 2 Receptors in Gelatinase Regulation in Human Carotid Atheroma in vitro.
Topics: Aged; Angiotensin II; Blotting, Western; Carotid Artery Diseases; Enzyme-Linked Immunosorbent Assay; Gelatinases; Gene Expression Regulation, Enzymologic; Humans; In Vitro Techniques; Male; Plaque, Atherosclerotic; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2 | 2016 |
Angiotensin II Destabilizes Coronary Plaques in Watanabe Heritable Hyperlipidemic Rabbits.
Topics: Angiotensin II; Animals; Coronary Artery Disease; Coronary Vessels; Disease Models, Animal; Genetic Predisposition to Disease; Heredity; Hyperlipoproteinemia Type II; Infusion Pumps, Implantable; Infusions, Subcutaneous; Myocardial Infarction; Phenotype; Plaque, Atherosclerotic; Rabbits; Time Factors | 2016 |
Xiaoxianggou attenuates atherosclerotic plaque formation in endogenous high Ang II ApoE(-/-) mice via the inhibition of miR-203 on the expression of Ets-2 in endothelial cells.
Topics: 3' Untranslated Regions; Angiotensin II; Animals; Aorta; Apolipoproteins E; Autoantibodies; Drugs, Chinese Herbal; Endothelial Cells; Gene Expression Regulation; Genes, Reporter; Lipoproteins, LDL; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Plaque, Atherosclerotic; Proto-Oncogene Protein c-ets-2 | 2016 |
The kinetics of angiotensin-I metabolism in human carotid atheroma: An emerging role for angiotensin (1-7).
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Carotid Artery Diseases; Chromatography, High Pressure Liquid; Disease Progression; Humans; Mass Spectrometry; Peptide Fragments; Plaque, Atherosclerotic; Time Factors | 2016 |
Angiotensin-(1-7) regulates angiotensin II-induced matrix metalloproteinase-8 in vascular smooth muscle cells.
Topics: Angiotensin I; Angiotensin II; Animals; Atherosclerosis; Cells, Cultured; Disease Models, Animal; Enzyme Activation; Humans; Matrix Metalloproteinase 8; Mice, Knockout, ApoE; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Plaque, Atherosclerotic; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Time Factors | 2017 |
Efficacy of simvastatin in reducing aortic dilatation in mouse models of abdominal aortic aneurysm.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Aorta, Thoracic; Aortic Aneurysm, Abdominal; Apolipoproteins E; Lipids; Male; Mice; Mice, Transgenic; Plaque, Atherosclerotic; Receptors, Lipoprotein; Simvastatin | 2010 |
Angiotensin II induces extracellular matrix metalloproteinase inducer expression via an AT1R dependent pathway in aortic atherosclerotic plaque in apolipoprotein E knockout mice.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Aorta; Apolipoproteins E; Basigin; Gene Expression Regulation; Lipids; Mice; Mice, Knockout; Plaque, Atherosclerotic; Protein Transport; RNA, Messenger; Signal Transduction; Staining and Labeling | 2012 |
Quiescin sulfhydryl oxidase (QSOX) is expressed in the human atheroma core: possible role in apoptosis.
Topics: Angiotensin II; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Apoptosis; Blotting, Western; Brefeldin A; Camptothecin; Carotid Arteries; Cell Differentiation; HeLa Cells; Human Umbilical Vein Endothelial Cells; Humans; Immunohistochemistry; Oxidoreductases Acting on Sulfur Group Donors; Plaque, Atherosclerotic | 2011 |
Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apolipoproteins E; Atherosclerosis; Carotid Artery Diseases; Carotid Artery, Common; CD36 Antigens; Disease Models, Animal; Disease Progression; Focal Adhesion Kinase 1; Gene Deletion; JNK Mitogen-Activated Protein Kinases; Lipids; Lipoproteins, LDL; Macrophages; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidases; Plaque, Atherosclerotic; Receptor, Angiotensin, Type 1; Rupture, Spontaneous; Superoxides; Tetrazoles; Time Factors; Valine; Valsartan | 2012 |
8-Hydroxy-2-deoxyguanosine prevents plaque formation and inhibits vascular smooth muscle cell activation through Rac1 inactivation.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Angiotensin II; Animals; Apolipoproteins E; Blotting, Western; Cell Movement; Cell Proliferation; Cells, Cultured; Chemotaxis; Deoxyguanosine; Immunoenzyme Techniques; Male; Mice; Mice, Knockout; Models, Molecular; Muscle, Smooth, Vascular; Oxidative Stress; Plaque, Atherosclerotic; rac1 GTP-Binding Protein; Reactive Oxygen Species; Superoxides; Vasoconstrictor Agents | 2012 |
Interaction of diabetes and ACE2 in the pathogenesis of cardiovascular disease in experimental diabetes.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Aortic Diseases; Apoptosis; Biomarkers; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Inflammation Mediators; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Peptidyl-Dipeptidase A; Plaque, Atherosclerotic; Telemetry | 2012 |
Role of matrix Gla protein in angiotensin II-induced exacerbation of vascular calcification.
Topics: Aged; Angiotensin II; Apoptosis; Blotting, Western; Calcium Phosphates; Calcium-Binding Proteins; Carotid Arteries; Carotid Artery Diseases; Caspase 3; Cells, Cultured; Core Binding Factor Alpha 1 Subunit; Cytokines; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Extracellular Matrix Proteins; Feedback, Physiological; Gene Expression Regulation; Humans; In Situ Nick-End Labeling; Inflammation Mediators; Matrix Gla Protein; Middle Aged; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NF-kappa B; Plaque, Atherosclerotic; Real-Time Polymerase Chain Reaction; Receptor, Angiotensin, Type 1; Signal Transduction; Time Factors; Transfection; Vascular Calcification | 2012 |
Endogenous renovascular hypertension combined with low shear stress induces plaque rupture in apolipoprotein E-deficient mice.
Topics: Angiotensin II; Animals; Apolipoproteins E; Blood Pressure; Carotid Artery Diseases; Carotid Artery, Common; Collagen; Collagenases; Disease Models, Animal; Female; Hemorrhage; Hypertension, Renovascular; Incidence; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Plaque, Atherosclerotic; Stress, Mechanical | 2012 |
Biomechanical modeling and morphology analysis indicates plaque rupture due to mechanical failure unlikely in atherosclerosis-prone mice.
Topics: Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Biomechanical Phenomena; Calcinosis; Computer Simulation; Dietary Fats; Humans; Image Processing, Computer-Assisted; Mice; Mice, Knockout; Models, Biological; Phenotype; Plaque, Atherosclerotic; Receptors, LDL; Stress, Mechanical | 2013 |